important variable antigens determining the acceptance or failure of grafts. However, even in HLA-matched transplants, there remain hundreds of antigenic differences between donor and recipient capable of initiating a serious immune response. This example has shown that there are antigens with less pervasive effects than HLA, such as UGT2B17 and Y chromosome-encoded proteins, that may be critical in some grafts but mismatched at lower frequencies. A key innovation in the work of McCarroll et al. 1 is the design of an association study tailored to the GVHD problem in looking not for overrepresentation of a particular allele, as in a standard case-control study, but rather for the specific property of individuals being mismatched in the donor-negative and recipient-positive pattern. Although it is possible to imagine genome-wide SNP analyses along similar lines, there are real problems of power in such analyses, and some restriction of the genes analyzed to a probable subset, as in this study, is probably necessary to arrive at statistically convincing results.
The clinical acceptance and importance of this work will ultimately depend upon the contribution UGT2B17 is shown to make to GVHD in wider studies, among which further independent replication will be the first step. Precisely because the UGT2B17 gene deletion is so variable in frequency, the incidence of the mismatch involved, and hence the importance of this locus in GVHD, will vary between different populations. match explains a lower proportion of GVHD incidence. Analysis of clinical outcome over a time course showed that in these donor-recipient pairs, GVHD incidence was unchanged for about 20 days after BMT, after which the excess of GVHD in those with UGT2B17 mismatch became evident. The UGT2B17 gene deletion variant is unusually variable in frequency (from 19% to 85%) between different populations 4 . Although this population differentiation may be indicative of selection, the differentiation is not in itself enough to distinguish selection from random drift in allele frequency. UGT2B17 encodes a protein with properties that suggest a mechanism for involvement in GVHD: it is a large protein (a 530-amino-acid UDP-glucuronyltransferase) and is expressed on the surface of cells in those tissues most frequently affected by GVHD. As such, it might be possible to detect the immune response to multiple antigens derived from this protein.
McCarroll et al. 1 further examined the serum of 26 individuals with GVHD, including 10 with UGT2B17-mismatched donors, against an array of peptides spanning the protein sequence. They found that the serum from one individual contained antibodies against an epitope derived from UGT2B17. They were able to fine map the relevant section of the protein involved in this response to a nine-amino-acid epitope and found that the antibodies distinguished this epitope from paralogous peptide sequences from other UGT2B genes.
Antigenic repertoire
This study addresses the extent of functionally relevant diversity in the antigenic repertoire between humans. The early days of tissue transplantation identified HLA as by far the most researchers 3 , the care taken to ensure accuracy of CNV genotyping is an important and exemplary feature of this study. In correlating the frequency of GVHD in different genotype combinations for donor and recipient, the prediction is that only a particular combination (donor negative and recipient positive for the genotype of interest) should be capable of leading to GVHD in the recipient. Of the six genes tested in this initial cohort, only UGT2B17 showed clear evidence of association between GVHD and (donor negative and recipient positive) mismatch (Fig. 1) .
For UGT2B17, donor-negative and recipientpositive mismatched pairs were about three times more likely to develop GVHD than pairs with other combinations of UGT2B17 alleles. This relative excess of UGT2B17-positive recipients receiving UGT2B17-negative grafts among GVHD sufferers was replicated on genotyping of two further cohorts totaling more than 900 transplant recipients. While the clinical background and ascertainment of GVHD differed between these two series, the association was significant within each cohort between those affected with GVHD and those unaffected. Reassuringly, the authors also confirmed that there was no association when the UGT2B17 mismatch was in the other direction (donor positive and recipient negative) or when both donor and recipient were UGT2B17 positive, suggesting that the association was indeed dependent on the specific donor-recipient mismatch at this locus. Combined analysis across the three cohorts and 1,345 donor-recipient pairs estimated that the odds ratio for the mismatch is about 2.5. This effect size is comparable to that of a sex mismatch in risk of GVHD, although because of the lower frequency of UGT2B17 mismatch between siblings, this mis- Leprosy has affected humans for at least 4,000 years 1 , with accounts of leprosy-like illnesses widespread though various cultures over many centuries. Once of global distribution, leprosy is now a curable infectious disease that nevertheless remains a major public health problem in Africa, Asia and, especially, South America. Attempts at global eradication are ongoing, with the WHO recently adopting a 'final push' strategy 2 . Despite its prominence and long history, many aspects of the biology of leprosy remain poorly understood, in large degree because the causative organism, the bacterium Mycobacterium leprae, remains uncultivable on artificial media. Advances have been slow and hard won 3 , but in recent years, the application of molecular genetics to leprosy has made a major contribution to our understanding of the disease, particularly the sequencing of the complete genome whereas a subset of SNPs is susceptible to phylogenetic discovery bias. This bias is introduced when two reference sequences are used to identify genetic variation that is assayed in a wider set of samples. As only the variation between the two reference sequences can be identified by these assays, many-and perhaps the most importantrelationships among the wider sample set are lost, potentially giving rise to highly misleading phylogenetic inferences 13 .
Putting leprosy on the map

Typing schemes evolve
Monot et al. 5 limited the problems of discovery bias by the genome sequencing of an additional strain of leprosy (Br4923, from Brazil) as geographically diverse in origin from the originally sequenced strain (TN, from India) as possible. These strains were therefore unlikely to share a very recent common ancestor. The genome sequence of strain Br4923 was determined at 6× coverage using parallel sequencing technologies and was very similar to the TN genome sequence, being only 141 bp smaller. There were a total of 194 polymorphic sites between the two sequences, comprising 155 SNPs, 31 VNTRs and eight deletion and insertion events. For additional comparison, they sequenced, at high coverage using Illumina technology, two additional strains from Thailand (Tha53 strain at 38× coverage) and the United States (NHDP63 strain at 46× coverage). These two strains also showed low genetic diversity, and from them, the authors identified 201 SNPs, many shared with either the TN or Br4923 strains. For typing purposes, they found the VNTR approach to be deficient and concentrated instead on a typing system based on informative mutations, identifying 78 informative SNPs from the genome sequences and surveying them in a set of 400 geographically diverse samples as well as some archaeological specimens. From these data they were able to classify strains into 16 SNP subtypes, which were clustered by geographical distribution and associated with patterns of human migration.
Single clone pathogens
The comparison of data from multiple M. leprae samples shows that they are all descendents of a single clone that underwent an extreme bottleneck and reductive evolution involving the inactivation of half of the genes in the chromosome 4, 14 . It seems likely that at least some of the pseudogene formation predates the association of M. leprae with humans, and an intermediate host, perhaps an invertebrate, may have been involved. The fact that all samples from of the M. leprae TN strain in 2001 (ref. 4) . This sequencing showed that the M. leprae genome was appreciably smaller than that of its nearest sequenced relative, M. tuberculosis (by about 1 Mb, or 25% of the genome), and that about half of the genome comprised inactivated pseudogenes. On page 1282 of this issue, Stuart Cole and colleagues 5 now report the sequencing of a second M. leprae genome, that of a Brazilian strain, Br4923, as well as high-coverage sequencing of two additional strains and genome-wide analysis of sequence variation in a set of geographically diverse samples, including some from archaeological specimens. This work provides a definitive framework for understanding the evolution and global spread of this notorious pathogen.
Leprosy's niche
Other than humans, the nine-banded armadillo remains the only immunologically competent animal that can be reliably infected to develop disseminated leprosy 3 . The first genome sequence of M. leprae suggested that this extreme fastidiousness can be ascribed to loss of metabolic capacity as a result of extensive gene decay 4 . These earlier genomic studies also indicated that M. leprae is derived from a single clone evolving asexually with no genetic exchange, a property shared with pathogens including Mycobacterium tuberculosis 6, 7 , Yersinia pestis 8 , Bacillus anthracis 9 , Salmonella enterica var. Typhi 10 and Treponema pallidum 11 . Although diverse in their origins and modes of transmission, these pathogens have all emerged recently, in evolutionary terms, by expansion into a new pathogenic niche but at the expense of participating in inter-and intraspecific genetic exchange (Fig. 1) .
The low levels of genetic exchange simplify investigations of the evolution and epidemiology of such pathogens, as their population structures conform to the clonal paradigm. Under this paradigm there is little or no genetic exchange and variation is in linkage disequilibrium. Their evolution is consequently accurately modeled by phylogenetic trees, the branches of which correspond to mutational events. The rarity of these events, however, presents the major challenge in the study of such bacteria, as large amounts of sequence need to be determined to identify relatively few informative characters 12 . For subtyping, therefore, either highly variable loci, such as VNTRs, or a subset of variable characters from multiple locations in the genome are typically chosen. These present difficulties of their own: VNTRs mutate and revert rapidly, obscuring patterns of descent, The pathogen becomes reproductively isolated from the ancestral population (right), and the pathogenic lifestyle precludes genetic exchange among members of the clone as it expands into its new niche. During expansion, the effects of purifying selection are reduced or eliminated by lack of competition with similar organisms, accompanied by genome degradation and a loss of fitness. Some adaptation to the host by positive selection may occur, but much of the change that occurs is reductive evolution due to the accumulation of deleterious mutations 15 . The accumulation of mutation in different branches generates a fingerprint of polymorphisms characteristic of each branch, enabling the phylogeny to be precisely reconstructed from whole-genome sequence data.
the accurate investigation of the epidemiology and evolution of M. leprae and other genetically monomorphic pathogens. With increasing accessibility of parallel sequencing technologies, we can anticipate epidemiological studies based on genome-wide variation of large numbers of microbiological specimens 13 . The development here of a more robust means of typing M. leprae samples based on this genome-wide and phylogenetic analysis will facilitate epidemiological and evolutionary studies as we move toward global disease eradication 2 . Application of this typing scheme to contemporary and historical specimens provides the prospect of establishing a complete or near-complete history of this fascinating pathogen, even in those areas where the disease has long been eradicated.
humans are genetically so similar (99.995% identical) shows that once in humans, this single clone has spread extensively through populations, with some ongoing reductive evolution evidenced by the discovery of an additional five pseudogenes in the sequence of Br4932. The geographic and temporal pattern of the genetic variation observed in 400 contemporary samples, together with types determined from ancient DNA present in archaeological specimens as old as 1,500 years, is consistent with human leprosy arising in humans in East Africa and spreading worldwide with human migrations and trade. Interestingly, this ancient disease appears to have been introduced into the Americas by the slave trade rather than older human migrations.
Monot et al. 5 shows the importance of whole-genome analysis of sequence data for
